Update information
Minor changes since publication
January 2019: Contact details for the patient access scheme for colistimethate sodium DPI (Colobreathe) updated because Colobreathe is now owned by Teva UK.
June 2013: Implementation note deleted from the start of section 1 because colistimethate sodium dry powder for inhalation is now available in the UK.
ISBN: 978-1-4731-3288-7